Google DeepMind Unveils AlphaProteo: A Revolutionary AI for Protein Design
Google DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
Read moreGoogle DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
Read moreIn a forward-thinking move, Sanofi, Formation Bio, and OpenAI have joined forces to harness the power of artificial intelligence in
Read moreThe AI-driven image analysis software, MMI CellDetector, is designed to automatically identify and quantify cellular phenotypes across a wide range
Read moreIn a proof-of-concept study, researchers at the National Institutes of Health (NIH) explored the feasibility of employing transfer learning, a machine
Read moreMachine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read moreAmerican biotechnology corporation Genentech, a key player in research and early drug development and a subsidiary of the Roche Group,
Read moreMcMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreA new Oxford-GSK Institute of Molecular and Computational Medicine will be established through a substantial five-year cooperation between GlaxoSmithKline plc
Read moreGoogle’s parent company Alphabet Inc has announced the launch of a new UK-based company called Isomorphic Labs, dedicated to applying
Read more